Get started
argenx SEargenx SEargenx SE

argenx SE

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFs
Full chart
Full chart

Compare with argenx SE



Key stats


Market capitalization
‪47.98 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
34.0
Basic EPS (TTM)
23.8 EUR
Net income (FY)
‪1.14 B‬ EUR
Revenue (FY)
‪3.68 B‬ EUR
Shares float
‪62.42 M‬
Beta (1Y)
1.19

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪1.86 K‬
Change (1Y)
+264+16.51%
Revenue / Employee (1Y)
‪1.98 M‬ EUR
Net income / Employee (1Y)
‪614.51 K‬ EUR

Details


Sector
Health Technology
Industry
Biotechnology
CEO
Karen Massey
Website
argen-x.com
Headquarters
Amsterdam
Founded
2008
IPO date
Jul 10, 2014
ISIN
NL0010832176
FIGI
BBG006MF2DW2
Identifiers
ISIN NL0010832176
CFI code
ESVUFN
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight0.13%
Market value‪844.45 M‬
VEA
Vanguard FTSE Developed Markets ETF
Weight0.17%
Market value‪561.03 M‬
IEFA
iShares Core MSCI EAFE ETF
Weight0.20%
Market value‪397.29 M‬
EFA
iShares MSCI EAFE ETF
Weight0.24%
Market value‪189.50 M‬
XESX
Xtrackers EURO STOXX 50 UCITS ETF Distribution 1D
Weight1.05%
Market value‪153.69 M‬
XESC
Xtrackers EURO STOXX 50 UCITS ETF Capitalisation 1C
Weight1.05%
Market value‪153.69 M‬
VGK
Vanguard FTSEEuropean ETF
Weight0.36%
Market value‪138.03 M‬
VEU
Vanguard FTSE All World Ex US ETF
Weight0.14%
Market value‪134.41 M‬
SCHF
Schwab International Equity ETF
Weight0.18%
Market value‪123.70 M‬
EXW1
iShares Core EURO STOXX 50 UCITS ETF (DE)
Weight1.02%
Market value‪112.63 M‬
CSSX5E.EUR
iShares Core EURO STOXX 50 UCITS ETF
Weight1.02%
Market value‪93.86 M‬

Explore more ETFs 

Frequently asked questions


The current price of ARGX is 748.2 EUR — it has decreased by −2.35% in the past 24 hours. Watch argenx SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange argenx SE stocks are traded under the ticker ARGX.
ARGX stock has risen by 3.60% compared to the previous week, the month change is a −6.26% fall, over the last year argenx SE has showed a 36.04% increase.
We've gathered analysts' opinions on argenx SE future price: according to them, ARGX price has a max estimate of 1,100.00 EUR and a min estimate of 810.00 EUR. Watch ARGX chart and read a more detailed argenx SE stock forecast: see what analysts think of argenx SE and suggest that you do with its stocks.
ARGX reached its all-time high on Jul 2, 2026 with the price of 833.6 EUR, and its all-time low was 6.2 EUR and was reached on Oct 16, 2014. View more price dynamics on ARGX chart.
See other stocks reaching their highest and lowest prices.
ARGX stock is 0.62% volatile and has beta coefficient of 1.19. Track argenx SE stock price on the chart and check out the list of the most volatile stocks — is argenx SE there?
Today argenx SE has the market capitalization of ‪47.98 B‬, it has increased by 1.79% over the last week.
Yes, you can track argenx SE financials in yearly and quarterly reports right on TradingView.
argenx SE is going to release the next earnings report on Mar 4, 2027. Keep track of upcoming events with our Earnings Calendar.
ARGX net income for the last half-year is ‪718.39 M‬ EUR, while the previous report showed ‪752.16 M‬ EUR of net income which accounts for 0.00% change. Track more argenx SE financial stats to get the full picture.
No, ARGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 12, 2026, the company has ‪1.86 K‬ employees. See our rating of the largest employees — is argenx SE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. argenx SE EBITDA is ‪1.32 B‬ EUR, and current EBITDA margin is 24.53%. See more stats in argenx SE financial statements.
Like other stocks, ARGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade argenx SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So argenx SE technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating argenx SE stock shows the buy signal. See more of argenx SE technicals for a more comprehensive analysis.